Document is current
Any future updates will be listed below
-
Authors
Li, Lanlan
Lui, David Tak-Wai
Fong, Carol Ho-Yi
Chow, Wing-Sun
Au, Ivan Chi-Ho
Xiong, Xi
Lang, Brian Hung-Hin
Wong, Carlos King-Ho
Lee, Chi-Ho
- License Information
-
More Information
Article History
Received: 11 June 2025
Accepted: 7 October 2025
First Online: 31 October 2025
Declarations
:
: The study protocol was approved by the Ethics Committee of the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (Reference Number: UW 15-613). Informed consent was not required as all data was anonymous.
: Not applicable.
: C.H.L received advisory board and lecture honorarium from AstraZeneca, Bayer, Boehringer Ingelheim, Echosens, Eli Lilly, Gilead, GSK, Novo Nordisk and Sanofi Aventis. C.K.H.W and X.X were supported by the AIR@InnoHK administered by Innovation and Technology Commission, Government of Hong Kong Special Administrative Region, China.
